Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Tridacaine II

Generic name: Lidocaine

FDA application holder: Actavis Labs UT Inc

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Tridacaine II?
Tridacaine II is a brand name of Lidocaine, a prescription medicine. The FDA NDC Directory lists 1 Tridacaine II product in 1 strength and form.
Who makes Tridacaine II?
Actavis Labs UT Inc holds the FDA application for Tridacaine II (ANDA200675, approved August 23, 2012).
Is there a generic or store brand of Tridacaine II?
Yes. The FDA NDC Directory lists 36 other products with the same active ingredients, strength and form as a Tridacaine II product, 36 of them generic. Ask your pharmacist whether one is right for you.
Has Tridacaine II been recalled?
No recall linked to Tridacaine II products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Tridacaine II is

Each Tridacaine II product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Lidocaine · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
lidocaine 5%
patch (topical)
Tridacaine II 36 products, 20 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lidocaine →

FDA approval

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
FDA applications of Tridacaine II products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
ANDA200675Actavis Labs UT IncAugust 23, 20121

Companies that list Tridacaine II

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Tridacaine II products.

Recalls

No recall linked to Tridacaine II products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers